MyMD Pharmaceuticals Inc MYMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:24 PM EDT
4.75quote price arrow up+0.02 (+0.42%)
Volume
11,141
52 week range
3.30 - 13.94

...

Loading . . .
  • Open4.68
  • Day High4.76
  • Day Low4.65
  • Prev Close4.73
  • 52 Week High13.94
  • 52 Week High Date08/10/20
  • 52 Week Low3.30
  • 52 Week Low Date05/17/21

Key Stats

  • Market Cap175.18M
  • Shares Out36.88M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.31
  • YTD % Change19.35

KEY STATS

  • Open4.68
  • Day High4.76
  • Day Low4.65
  • Prev Close4.73
  • 52 Week High13.94
  • 52 Week High Date08/10/20
  • 52 Week Low3.30
  • 52 Week Low Date05/17/21
  • Market Cap175.18M
  • Shares Out36.88M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.31
  • YTD % Change19.35

RATIOS/PROFITABILITY

  • EPS (TTM)-2.79
  • P/E (TTM)-1.70
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-10.201M
  • ROE (MRQ)-50.73%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-335.96%
  • Net Margin (MRQ)-13,049.39%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MyMD Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
MyMD Pharmaceuticals, Inc., formerly Akers Biosciences, Inc., is a clinical stage pharmaceutical company. The Company is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. MyMD-1 is being developed to...
Joshua Silverman
Chairman
Chris Chapman M.D.
President
Ian Rhodes
Chief Financial Officer
Paul Rivard Esq., J.D.
Executive Vice President
Address
855 N. WOLFE STREET, SUITE 623
Baltimore, MD
21205
United States

Top Peers

SYMBOLLASTCHG%CHG
SINT
SINTX Technologies Inc
1.66-0.03-1.79%
BMRA
Biomerica Inc
3.80+0.10+2.70%
NBY
NovaBay Pharmaceuticals Inc
0.6662+0.0072+1.09%
ULUR
ULURU Inc
0.2601UNCHUNCH
MLSS
Milestone Scientific Inc
1.97-0.05-2.48%
RMTI
Rockwell Medical Inc
0.7272-0.0125-1.6899%